125 related articles for article (PubMed ID: 16170225)
1. Will pharmacogenomic discoveries improve HIV therapeutics?
Haas DW
Top HIV Med; 2005; 13(3):90-5. PubMed ID: 16170225
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.
Haas DW; Smeaton LM; Shafer RW; Robbins GK; Morse GD; Labbe L; Wilkinson GR; Clifford DB; D'Aquila RT; De Gruttola V; Pollard RB; Merigan TC; Hirsch MS; George AL; Donahue JP; Kim RB
J Infect Dis; 2005 Dec; 192(11):1931-42. PubMed ID: 16267764
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.
Cressey TR; Lallemant M
Infect Genet Evol; 2007 Mar; 7(2):333-42. PubMed ID: 17045554
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of antiretrovirals.
Tozzi V
Antiviral Res; 2010 Jan; 85(1):190-200. PubMed ID: 19744523
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of HIV therapy.
Owen A; Pirmohamed M; Khoo SH; Back DJ
Pharmacogenet Genomics; 2006 Oct; 16(10):693-703. PubMed ID: 17001288
[TBL] [Abstract][Full Text] [Related]
6. Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.
Motsinger AA; Ritchie MD; Shafer RW; Robbins GK; Morse GD; Labbe L; Wilkinson GR; Clifford DB; D'Aquila RT; Johnson VA; Pollard RB; Merigan TC; Hirsch MS; Donahue JP; Kim RB; Haas DW
Pharmacogenet Genomics; 2006 Nov; 16(11):837-45. PubMed ID: 17047492
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and the potential for the individualization of antiretroviral therapy.
Phillips EJ; Mallal SA
Curr Opin Infect Dis; 2008 Feb; 21(1):16-24. PubMed ID: 18192781
[TBL] [Abstract][Full Text] [Related]
8. The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.
Michaud V; Bar-Magen T; Turgeon J; Flockhart D; Desta Z; Wainberg MA
Pharmacol Rev; 2012 Jul; 64(3):803-33. PubMed ID: 22759796
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity.
Martin AM; Nolan D; Gaudieri S; Phillips E; Mallal S
Pharmacogenomics; 2004 Sep; 5(6):643-55. PubMed ID: 15335286
[TBL] [Abstract][Full Text] [Related]
10. HIV pharmacogenomics: closer to personalized therapy?
Payne DA; Bryant BJ;
Am J Pharmacogenomics; 2004; 4(3):141-50. PubMed ID: 15174895
[TBL] [Abstract][Full Text] [Related]
11. Human genetic variability and HIV treatment response.
Haas DW
Curr HIV/AIDS Rep; 2006 Jul; 3(2):53-8. PubMed ID: 16608660
[TBL] [Abstract][Full Text] [Related]
12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
13. Individualising HIV treatment--pharmacogenetics and immunogenetics.
Telenti A; Aubert V; Spertini F
Lancet; 2002 Mar; 359(9308):722-3. PubMed ID: 11888578
[No Abstract] [Full Text] [Related]
14. Genotypic and phenotypic nevirapine resistance correlates with virological failure during salvage therapy including abacavir and nevirapine.
Jørgensen LB; Katzenstein TL; Gerstoft J; Mathiesen LR; Pedersen C; Nielsen C
Antivir Ther; 2000 Sep; 5(3):187-94. PubMed ID: 11075938
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacogenetics. Tailored therapy in medicine -- opportunities and challenges].
Scharplatz M; Puhan M; Steurer J; Bachmann LM
Praxis (Bern 1994); 2004 Mar; 93(10):359-65. PubMed ID: 15052854
[TBL] [Abstract][Full Text] [Related]
16. The pharmacogenetics of antiretroviral therapy: a review of studies to date.
Quirk E; McLeod H; Powderly W
Clin Infect Dis; 2004 Jul; 39(1):98-106. PubMed ID: 15206060
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?
Nolan D; Gaudieri S; Mallal S
J HIV Ther; 2003 May; 8(2):36-41. PubMed ID: 12838163
[TBL] [Abstract][Full Text] [Related]
19. HIV pharmacogenetics in clinical practice: recent achievements and future challenges.
Tozzi V; Libertone R; Liuzzi G
Curr HIV Res; 2008 Nov; 6(6):544-54. PubMed ID: 18991620
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
Eshleman SH; Krogstad P; Jackson JB; Wang YG; Lee S; Wei LJ; Cunningham S; Wantman M; Wiznia A; Johnson G; Nachman S; Palumbo P
J Infect Dis; 2001 Jun; 183(12):1732-8. PubMed ID: 11372025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
